INMB CIK: 1711754

Inmune Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.5
FY22:
−22.7
FY23:
−12.0
FY24:
−33.4
FY25:
−22.6
Change from FY21 to FY25
millions USD
FY21:
−15.0
FY22:
–
FY23:
–
FY24:
–
FY25:
−1.04
Change from FY21 to FY25
millions USD
FY21:
96.4
FY22:
0.73
FY23:
−4.23
FY24:
18.2
FY25:
27.6
millions USD
FY21:
52.8
FY22:
−22.7
FY23:
−16.3
FY24:
−14.9
FY25:
3.83
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−23.6

All amounts in millions USD Data source:SEC EDGAR